Hemolysis Following Intraoperative Cell Salvage Replacement in a Scoliosis Patient With Sickle Cell Trait: A Case Report.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7610646 Publication Model: Print Cited Medium: Internet ISSN: 1528-1159 (Electronic) Linking ISSN: 03622436 NLM ISO Abbreviation: Spine (Phila Pa 1976) Subsets: MEDLINE
    • Publication Information:
      Publication: Hagerstown, MD : Lippincott Williams & Wilkins
      Original Publication: Hagerstown, Md., Medical Dept., Harper & Row.
    • Subject Terms:
      Blood Transfusion, Autologous/*adverse effects ; Hemolysis/*physiology ; Intraoperative Care/*adverse effects ; Scoliosis/*surgery ; Sickle Cell Trait/*surgery; Acute Kidney Injury/diagnostic imaging ; Acute Kidney Injury/etiology ; Adolescent ; Blood Transfusion, Autologous/methods ; Female ; Hematologic Tests/methods ; Humans ; Intraoperative Care/methods ; Neurosurgical Procedures/adverse effects ; Scoliosis/complications ; Scoliosis/diagnostic imaging ; Sickle Cell Trait/complications ; Sickle Cell Trait/diagnostic imaging ; Spinal Fusion/adverse effects ; Spinal Fusion/methods
    • Abstract:
      MINI: Intraoperative cell salvage (ICS) is used to reduce blood loss in scoliosis spinal fusion. We report one case of hemolysis induced acute renal failure following ICS. This is the first reported case of acute renal failure associated with hemolysis following ICS in a scoliosis patient with sickle cell trait.
      Study Design: Case report.
      Objective: To describe a novel presentation of acute renal failure associated with hemolysis after intraoperative cell salvage (ICS) in a neuromuscular scoliosis patient with sickle cell trait (SCT).
      Summary of Background Data: Hemolysis-associated acute renal failure after ICS in patients with SCT has not been previously reported. Sickle cell disease is regarded as a relative contraindication for ICS due to the risk of red blood cell sickling in the hypoxic cell saver reservoir. A previous case series demonstrated successful ICS reinfusion after elective caesarean section in two patients with SCT. However, a decision to not reinfuse ICS collected blood due to increased sickling after blood processing was reported in general surgery.
      Methods: A 14-year-old female with Group I neuromuscular scoliosis underwent a navigated T3-S1posterior spinal instrumentation fusion. Three hundred milliliters of blood collected by ICS was reinfused intraoperatively along with two units of packed red blood cells.
      Results: Postoperatively, the patient had delayed emergence from the general anesthetic and gross hematuria was observed in the urinary catheter bag. The patient was transferred to the intensive care unit and was treated successfully for hemolysis-induced renal failure.
      Conclusion: Given the potential seriousness of hemolysis-associated acute renal failure associated with ICS, we recommend against the use of ICS in patients with SCT.
      Level of Evidence: 5.
    • References:
      Thompson GH, Florentino-Pineda I, Poe-Kochert C, et al. Role of amicar in surgery for neuromuscular scoliosis. Spine (Phila Pa 1976) 2008; 33:2623–2629.
      Dhawale AA, Shah SA, Sponseller PD, et al. Are antifibrinolytics helpful in decreasing blood loss and transfusions during spinal fusion surgery in children with cerebral palsy scoliosis? Spine (Phila Pa 1976) 2012; 37:E549–E555.
      Da Cunha RJ, Sayegh AS, LaMothe JM, et al. Intraoperative skull-femoral traction in posterior spinal arthrodesis for adolescent idiopathic scoliosis. Spine (Phila Pa 1976) 2015; 40:E154–E160.
      DeAndrade D, Waters JH, Triulzi DJ, et al. Very low rate of patient-related adverse events associated with the use of intraoperative cell salvage. Transfusion 2016; 56:2768–2772.
      Copley LA, Richards BS, Safavi FZ, et al. Hemodilution as a method to reduce transfusion requirements in adolescent spine fusion surgery. Spine (Phila Pa 1976) 1999; 24:219–222.
      Halawi MJ, Lark RK, Fitch RD. Neuromuscular scoliosis: current concepts. Orthopedics 2015; 38:452–456.
      Brenn BR, Theroux MC, Dabney KW, et al. Clotting parameters and thromboelastography in children with neuromuscular and idiopathic scoliosis undergoing posterior spinal fusion. Spine (Phila Pa 1976) 2004; 29:E310–E314.
      Meert KL, Kannan S, Mooney JF. Predictors of red cell transfusion in children and adolescents undergoing spinal fusion surgery. Spine (Phila Pa 1976) 2002; 27:2137–2142.
      Carson JL, Grossman BJ, Kleinman S, et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med 2012; 157:49–58.
      Stone N, Sardana V, Missiuna P. Indications and outcomes of cell saver in adolescent scoliosis correction surgery. Spine (Phila Pa 1976) 2016; 42:1–20.
      Esper SA, Waters JH. Intra-operative cell salvage: a fresh look at the indications and contraindications. Blood Transfus 2011; 9:139–147.
      Sullivan IJ, Faulds JN. Assessment of intra-operative cell salvage haemolysis in the obstetric and orthopaedic clinical setting, in comparison with allogeneic blood. Transfus Med 2014; 24:280–285.
      Brajtbord D, Johnson D, Ramsay M, et al. Use of the cell saver in patients with sickle cell trait. Anesthesiology 1989; 70:878–879.
      Okunuga A, Skelton VA. Use of cell salvage in patients with sickle cell trait. Int J Obstet Anesth 2009; 18:90–91.
    • Publication Date:
      Date Created: 20170426 Date Completed: 20190603 Latest Revision: 20210115
    • Publication Date:
      20221213
    • Accession Number:
      10.1097/BRS.0000000000002211
    • Accession Number:
      28441316